BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Currier MG, Lee S, Stobart CC, Hotard AL, Villenave R, Meng J, Pretto CD, Shields MD, Nguyen MT, Todd SO, Chi MH, Hammonds J, Krumm SA, Spearman P, Plemper RK, Sakamoto K, Peebles RS Jr, Power UF, Moore ML. EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression. PLoS Pathog 2016;12:e1005622. [PMID: 27152417 DOI: 10.1371/journal.ppat.1005622] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Rios Guzman E, Hultquist JF. Clinical and biological consequences of respiratory syncytial virus genetic diversity. Ther Adv Infect Dis 2022;9:20499361221128091. [PMID: 36225856 DOI: 10.1177/20499361221128091] [Reference Citation Analysis]
2 Narayan Talukdar S, Mehedi M. Respiratory Syncytial Virus. RNA Viruses Infection [Working Title] 2022. [DOI: 10.5772/intechopen.104771] [Reference Citation Analysis]
3 Du X, Yuan L, Yao Y, Yang Y, Zhou K, Wu X, Wang L, Qin L, Li W, Xiang Y, Qu X, Liu H, Qin X, Yang M, Liu C. ITGB4 Deficiency in Airway Epithelium Aggravates RSV Infection and Increases HDM Sensitivity. Front Immunol 2022;13:912095. [DOI: 10.3389/fimmu.2022.912095] [Reference Citation Analysis]
4 Lai KM, Lee WL. The roles of epidermal growth factor receptor in viral infections. Growth Factors 2022;40:46-72. [PMID: 35439043 DOI: 10.1080/08977194.2022.2063123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ruysseveldt E, Martens K, Steelant B. Airway Basal Cells, Protectors of Epithelial Walls in Health and Respiratory Diseases. Front Allergy 2021;2:787128. [PMID: 35387001 DOI: 10.3389/falgy.2021.787128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Feng Z, Xu L, Xie Z. Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus. Front Cell Infect Microbiol 2022;12:858629. [DOI: 10.3389/fcimb.2022.858629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kazybay B, Ahmad A, Mu C, Mengdesh D, Xie Y. Omicron N501Y mutation among SARS-CoV-2 lineages: In-silico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine. Travel Med Infect Dis 2021;:102242. [PMID: 34929375 DOI: 10.1016/j.tmaid.2021.102242] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
8 Bergeron HC, Tripp RA. Immunopathology of RSV: An Updated Review. Viruses 2021;13:2478. [PMID: 34960746 DOI: 10.3390/v13122478] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
9 McClelland RD, Culp TN, Marchant DJ. Imaging Flow Cytometry and Confocal Immunofluorescence Microscopy of Virus-Host Cell Interactions. Front Cell Infect Microbiol 2021;11:749039. [PMID: 34712624 DOI: 10.3389/fcimb.2021.749039] [Reference Citation Analysis]
10 Shang Z, Tan S, Ma D. Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies. Int J Biol Sci 2021;17:4073-91. [PMID: 34671221 DOI: 10.7150/ijbs.64762] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Li Y, Tang XX. Abnormal Airway Mucus Secretion Induced by Virus Infection. Front Immunol 2021;12:701443. [PMID: 34650550 DOI: 10.3389/fimmu.2021.701443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Shilovskiy IP, Yumashev KV, Nikolsky AA, Vishnyakova LI, Khaitov MR. Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Using Murine Models to Understand Human Pathology. Biochemistry (Mosc) 2021;86:290-306. [PMID: 33838630 DOI: 10.1134/S0006297921030068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Шиловский И, Юмашев К, Никольский А, Вишнякова Л, Хаитов М. Молекулярные и клеточные механизмы патогенеза респираторно-синцитиальной вирусной инфекции. Новые данные на экспериментальных моделях. БМ 2021;86:341-359. [DOI: 10.31857/s0320972521030052] [Reference Citation Analysis]
14 Ramaekers K, Rector A, Cuypers L, Lemey P, Keyaerts E, Van Ranst M. Towards a unified classification for human respiratory syncytial virus genotypes. Virus Evol 2020;6:veaa052. [PMID: 33072402 DOI: 10.1093/ve/veaa052] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
15 Griffiths CD, Bilawchuk LM, Mcdonough JE, Jamieson KC, Elawar F, Cen Y, Duan W, Lin C, Song H, Casanova J, Ogg S, Jensen LD, Thienpont B, Kumar A, Hobman TC, Proud D, Moraes TJ, Marchant DJ. IGF1R is an entry receptor for respiratory syncytial virus. Nature 2020;583:615-9. [DOI: 10.1038/s41586-020-2369-7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 24.0] [Reference Citation Analysis]
16 Nikonova AA, Isakov IY, Zverev VV. Immune response to respiratory syncytial virus infection (<i>Orthopneumovirus</i>). Russian Journal of Infection and Immunity 2020;11:223-236. [DOI: 10.15789/2220-7619-irt-1300] [Reference Citation Analysis]
17 Hu M, Bogoyevitch MA, Jans DA. Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies. Physiol Rev 2020;100:1527-94. [PMID: 32216549 DOI: 10.1152/physrev.00030.2019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
18 Aggarwal M, Plemper RK. Structural Insight into Paramyxovirus and Pneumovirus Entry Inhibition. Viruses 2020;12:E342. [PMID: 32245118 DOI: 10.3390/v12030342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
19 Tahamtan A, Samadizadeh S, Rastegar M, Nakstad B, Salimi V. Respiratory syncytial virus infection: why does disease severity vary among individuals? Expert Rev Respir Med 2020;14:415-23. [PMID: 31995408 DOI: 10.1080/17476348.2020.1724095] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
20 Battles MB, McLellan JS. Respiratory syncytial virus entry and how to block it. Nat Rev Microbiol 2019;17:233-45. [PMID: 30723301 DOI: 10.1038/s41579-019-0149-x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 95] [Article Influence: 45.0] [Reference Citation Analysis]
21 Anderson LJ, Peret TC, Piedra PA. RSV Strains and Disease Severity. J Infect Dis 2019;219:514-6. [PMID: 30215722 DOI: 10.1093/infdis/jiy498] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 P. Legg J. Disease Severity in Respiratory Syncytial Virus Infection: Role of Viral and Host Factors. The Burden of Respiratory Syncytial Virus Infection in the Young 2019. [DOI: 10.5772/intechopen.88782] [Reference Citation Analysis]
23 McAllister CS, Ansaldi D, Growcott EJ, Zhong Y, Quackenbush D, Wolff KC, Chen Z, Tanaseichuk O, Lelais G, Barnes SW, Federe GC, Luna F, Walker JR, Zhou Y, Kuhen KL. Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling. Virology 2020;540:195-206. [PMID: 31929001 DOI: 10.1016/j.virol.2019.10.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
24 Boyoglu-Barnum S, Chirkova T, Anderson LJ. Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development. Front Immunol 2019;10:1675. [PMID: 31402910 DOI: 10.3389/fimmu.2019.01675] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
25 Jones HG, Battles MB, Lin CC, Bianchi S, Corti D, McLellan JS. Alternative conformations of a major antigenic site on RSV F. PLoS Pathog 2019;15:e1007944. [PMID: 31306469 DOI: 10.1371/journal.ppat.1007944] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
26 Mukherjee T, Balaji KN. Immunological implications of epidermal growth factor receptor signaling in persistent infections. IUBMB Life 2019;71:1661-71. [PMID: 31283086 DOI: 10.1002/iub.2115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Ezzat K, Pernemalm M, Pålsson S, Roberts TC, Järver P, Dondalska A, Bestas B, Sobkowiak MJ, Levänen B, Sköld M, Thompson EA, Saher O, Kari OK, Lajunen T, Sverremark Ekström E, Nilsson C, Ishchenko Y, Malm T, Wood MJA, Power UF, Masich S, Lindén A, Sandberg JK, Lehtiö J, Spetz AL, El Andaloussi S. The viral protein corona directs viral pathogenesis and amyloid aggregation. Nat Commun 2019;10:2331. [PMID: 31133680 DOI: 10.1038/s41467-019-10192-2] [Cited by in Crossref: 111] [Cited by in F6Publishing: 117] [Article Influence: 37.0] [Reference Citation Analysis]
28 San-Juan-Vergara H, Peeples ME. Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease. Immunol Allergy Clin North Am 2019;39:321-34. [PMID: 31284923 DOI: 10.1016/j.iac.2019.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Pandya MC, Callahan SM, Savchenko KG, Stobart CC. A Contemporary View of Respiratory Syncytial Virus (RSV) Biology and Strain-Specific Differences. Pathogens 2019;8:E67. [PMID: 31117229 DOI: 10.3390/pathogens8020067] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
30 Gao L, Tang W, Xie J, Chen S, Ren L, Zang N, Xie X, Deng Y, Liu E. Respiratory syncytial virus activates Rab5a to suppress IRF1-dependent IFN-λ production, subverting the antiviral defense of airway epithelial cells.. [DOI: 10.1101/547182] [Reference Citation Analysis]
31 Kiedrowski MR, Bomberger JM. Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract. Front Immunol 2018;9:3067. [PMID: 30619379 DOI: 10.3389/fimmu.2018.03067] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 14.3] [Reference Citation Analysis]
32 Hicks SN, Chaiwatpongsakorn S, Costello HM, McLellan JS, Ray W, Peeples ME. Five Residues in the Apical Loop of the Respiratory Syncytial Virus Fusion Protein F2 Subunit Are Critical for Its Fusion Activity. J Virol 2018;92:e00621-18. [PMID: 29743373 DOI: 10.1128/JVI.00621-18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
33 Symmes BA, Stefanski AL, Magin CM, Evans CM. Role of mucins in lung homeostasis: regulated expression and biosynthesis in health and disease. Biochem Soc Trans 2018;46:707-19. [PMID: 29802217 DOI: 10.1042/BST20170455] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
34 Lulli D, Carbone ML, Pastore S. Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skin. Oncotarget 2016;7:47777-93. [PMID: 27322144 DOI: 10.18632/oncotarget.10013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
35 Kalinowski A, Galen BT, Ueki IF, Sun Y, Mulenos A, Osafo-Addo A, Clark B, Joerns J, Liu W, Nadel JA, Dela Cruz CS, Koff JL. Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium. Mucosal Immunol 2018;11:958-67. [PMID: 29411775 DOI: 10.1038/mi.2017.120] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
36 Dadashi M, Goudarzi H, Owlia P, Faghihloo E. Prevalence of human respiratory syncytial virus in Iran: a systematic review and meta-analysis. Future Virology 2018;13:61-72. [DOI: 10.2217/fvl-2017-0055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Salas A, Pardo-Seco J, Cebey-López M, Gómez-Carballa A, Obando-Pacheco P, Rivero-Calle I, Currás-Tuala MJ, Amigo J, Gómez-Rial J, Martinón-Torres F; GENDRES network. Whole Exome Sequencing reveals new candidate genes in host genomic susceptibility to Respiratory Syncytial Virus Disease. Sci Rep 2017;7:15888. [PMID: 29162850 DOI: 10.1038/s41598-017-15752-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
38 Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev 2017;30:277-319. [PMID: 27903593 DOI: 10.1128/CMR.00010-16] [Cited by in Crossref: 266] [Cited by in F6Publishing: 280] [Article Influence: 53.2] [Reference Citation Analysis]
39 Ho J, Moyes DL, Tavassoli M, Naglik JR. The Role of ErbB Receptors in Infection. Trends Microbiol 2017;25:942-52. [PMID: 28522156 DOI: 10.1016/j.tim.2017.04.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
40 Majumdar T, Dhar J, Patel S, Kondratov R, Barik S. Circadian transcription factor BMAL1 regulates innate immunity against select RNA viruses. Innate Immun 2017;23:147-54. [PMID: 27913791 DOI: 10.1177/1753425916681075] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]